(Q39863989)

15 September 2017

title

Effects of bosentan on the skin lesions: an observational study from a single center in Japan (English)

1 reference

15 September 2017

Masanori Funauchi

1

1 reference

15 September 2017

K Kishimoto

2

1 reference

15 September 2017

H Shimazu

3

1 reference

15 September 2017

Y Nagare

4

1 reference

15 September 2017

S Hino

5

1 reference

15 September 2017

T Yano

6

1 reference

15 September 2017

K Kinoshita

7

1 reference

15 September 2017

publication date

27 November 2008

1 reference

Rheumatology International

15 September 2017

published in

1 reference

15 September 2017

volume

29

1 reference

15 September 2017

issue

7

1 reference

15 September 2017

page(s)

769-775

1 reference

https://scigraph.springernature.com/pub.10.1007/s00296-008-0789-z

15 September 2017

exact match

0 references

cites work

Adult patients with congenital heart disease and pulmonary arterial hypertension: first open prospective multicenter study of bosentan therapy

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00296-008-0789-Z

Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00296-008-0789-Z

Successful treatment of systemic sclerosis-related digital ulcers and sarcoidosis with endothelin receptor antagonist (bosentan) therapy.

21 January 2018

1 reference

12 December 2020

Results of European post-marketing surveillance of bosentan in pulmonary hypertension.

1 reference

12 December 2020

Le bosentan dans le traitement des ulcères digitaux évolutifs au cours de la sclérodermie systémique (9 cas)

1 reference

12 December 2020

Psychophysical bases of perceived exertion

1 reference

12 December 2020

Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children

1 reference

12 December 2020

Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

1 reference

12 December 2020

[Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)]

1 reference

12 December 2020

Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan.

1 reference

12 December 2020

The endothelin system in pulmonary arterial hypertension

1 reference

12 December 2020

Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension

1 reference

12 December 2020

Bosentan for severe pulmonary arterial hypertension related to systemic sclerosis with interstitial lung disease

1 reference

12 December 2020

Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

1 reference

12 December 2020

The course of skin involvement in systemic sclerosis over three years in a trial of chlorambucil versus placebo

1 reference

12 December 2020

Bosentan: a review of its use in pulmonary arterial hypertension and systemic sclerosis

1 reference

12 December 2020

Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale

1 reference

12 December 2020

Role of endothelial damage in the pathogenesis of interstitial pneumonitis in patients with polymyositis and dermatomyositis

1 reference

12 December 2020

Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)

1 reference

12 December 2020

Bosentan as a rescue therapy in scleroderma refractory digital ulcers.

1 reference

12 December 2020

Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcers

1 reference

12 December 2020

Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts

1 reference

12 December 2020

Role of endothelin in fibrosis and anti-fibrotic potential of bosentan

1 reference

12 December 2020

Long-term prognosis of 69 patients with dermatomyositis or polymyositis

1 reference

12 December 2020

Bosentan therapy of pulmonary arterial hypertension in connective tissue diseases

1 reference

12 December 2020

10.1007/S00296-008-0789-Z

Identifiers

DOI

1 reference

release_cj2qendpk5aoxagzdxmeufpo6i

15 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cj2qendpk5aoxagzdxmeufpo6i

24 November 2022

mapped directly with Wikidata item

1 reference